HSPA9 and breast cancer: In a human erythroleukemic cell line K562, mortalin (GRP75) promotes C5b-9 shedding in vesicles (29), while blocking EV release by mortalin knockdown or treatment with antagonist peptides restored complement mediated cytotoxicity in K562 and two breast cancer cells lines (30).